TEPEZZA Has Resumed Production - FAQ | oneGRAVESvoice

welcome to oneGRAVESvoice

- a positively charged Graves' disease and thyroid eye disease community.
  • join today!
rareCurate learn more
view full news & meetings section

TEPEZZA Has Resumed Production – FAQ


Horizon Therapeutics, the developer of TEPEZZA, prepared this document to address questions from the Thyroid Eye Disease (TED) community about the resumed production of TEPEZZA, a medicine for TED. Patients can now schedule their infusions. Read on for information about how to schedule infusions, insurance considerations and answers to other frequently asked questions.

Note: If you choose to share or post these FAQs, please share the full document and not select pieces of it, in order to comply with regulatory guidelines.

Questions about TEPEZZA? Talk to Horizon Patient Services.

Call 1-833-469-8331, Mon-Fri, 8 AM – 8 PM EST.

Horizon Patient Services does not provide individual patient care or medical advice.

TEPEZZA Has Resumed Production – FAQ
Source: https://www.hzndocs.com/tepezza-short-term-supply-disruption-FAQ.pdf

Disclaimer: Horizon supports the mission of oneGRAVESvoice and has provided financial support for this platform. Horizon neither owns or controls this platform, and unless expressly stated otherwise, does not have editorial control over content or responsibility for any other information or services.

rareRelated